Log in
Enquire now
‌

US Patent 9353141 Galectoside inhibitors of galectins

Patent 9353141 was granted and assigned to Galecto Biotech on May, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Galecto Biotech
Galecto Biotech
0
Current Assignee
Galecto Biotech
Galecto Biotech
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
93531410
Patent Inventor Names
Vishal Rajput0
Balaram Mukhopadhyay0
Hakon Leffler0
Ulf Nilsson0
Date of Patent
May 31, 2016
0
Patent Application Number
143641690
Date Filed
January 24, 2013
0
Patent Primary Examiner
‌
Traviss C Mcintosh, III
0
Patent abstract

The present invention relates to novel compounds prepared from readily accessible 3-O-propargyl-D-galactopyranoside derivatives and having an effect as i.a., galectin inhibitors, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to ligands in a mammal, wherein said galectin is preferably a galectin-3. The novel compounds are defined by the general formula (I).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9353141 Galectoside inhibitors of galectins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.